Drawing for MYLAN SPECIALTY

USPTO serial 85618596

MYLAN SPECIALTY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WILLISTON, JENNIFER LYNN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYLAN SPECIALTY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of respiratory disorders, asthma, allergies and allergic emergencies; pharmaceutical preparations for the treatment of chronic obstructive pulmonary disease; unit dose and multi-dose pharmaceutical preparations, namely, sterile purified water and sterile sodium chloride solutions and sterile bronchodilator solutions for inhalation for the treatment of lung and other respiratory system conditions; mucolytic agents for inhalation and for oral administration for use in the treatment of lung and other respiratory system conditions; inhalers filled with pharmaceutical preparations for the treatment of lung and other respiratory system conditions; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for the treatment of depression and other neurological and/or mental conditions or diseases administered through a transdermal patchACTIVE—
010Medical apparatus and devices for respiration therapy, namely, medical nebulizers, medical nebulizer adapters, medical nebulizer sets comprised of a nebulizer, a tee, a mouthpiece, a flexible tube, and a two-meter connecting tube sold as a unit for medical use, and nebulizers and holding chamber apparatus for use with metered dose inhalers; a medical apparatus in the nature of an attachment for medical inhalers which breaks down the molecules to allow easier entry into the lungs; metered dose inhalers for medical purposes sold empty, peak flow meters for medical use, medical fluid injectors; medical instruments and apparatus for the treatment of respiratory disorders, asthma, allergies and allergic emergenciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 11, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 11, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 24, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2014EX4GSOU EXTENSION 4 GRANTED—
Oct 6, 2014EXT4SOU EXTENSION 4 FILED—
Oct 6, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 12, 2014CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 12, 2014COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 12, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 15, 2014EX3GSOU EXTENSION 3 GRANTED—
Apr 8, 2014EXT3SOU EXTENSION 3 FILED—
Apr 8, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 30, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2013EX2GSOU EXTENSION 2 GRANTED—
Oct 25, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 26, 2013EXT2SOU EXTENSION 2 FILED—
Sep 26, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 9, 2013EX1GSOU EXTENSION 1 GRANTED—
Apr 9, 2013EXT1SOU EXTENSION 1 FILED—
Apr 9, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 9, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 14, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 14, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 25, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 9, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 9, 2012ALIEASSIGNED TO LIE—
Jun 19, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 2012XAECEXAMINER'S AMENDMENT ENTERED—
Jun 19, 2012GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 19, 2012GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 19, 2012CNEAEXAMINERS AMENDMENT -WRITTEN—
May 29, 2012GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 29, 2012GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 29, 2012CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
May 22, 2012DOCKASSIGNED TO EXAMINER—
May 14, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance